Rocuronium Injection, Solution
Product Images NDC 63323-426

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Rocuronium (NDC 63323-426). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Roc04 0004 01

Roc04 0004 01
Chemical structure of rocuronium bromide showing its detailed molecular arrangement, including carbon, hydrogen, nitrogen, oxygen atoms, and a bromide ion (Br-). The molecular formula C32H53BrN2O4 and molecular weight 609.70 are indicated.*
FDA Label Image

Roc04 0004 02

Roc04 0004 02
A scatter plot with box plots showing the distribution of a variable measured in minutes across different age groups (18–64 years, 65 years and older, and 1–12 years) and dosages in mg/kg. The x-axis represents dosage in mg/kg segmented by age groups, and the y-axis represents time in minutes. Individual data points and summary box plots are displayed for each group.*
FDA Label Image

Roc04 0004 03

Roc04 0004 03
A box plot chart presenting time measured in minutes on the vertical axis, categorized by age groups on the horizontal axis, ranging from 18-64 years to 1-12 years. The chart likely depicts distribution of a specific time-related variable across these age groups.*
FDA Label Image

Roc04 0004 04

Roc04 0004 04
A line graph showing time in minutes on the vertical axis and dose number on the horizontal axis. Two dose groups, 0.1 mg/kg and 0.15 mg/kg, are plotted, illustrating temporal changes in minutes across five dose exposures with respective sample sizes of 29 and 13.*
FDA Label Image

Roc04 0004 05

FDA Label Image

Roc04 0004 06

Roc04 0004 06
Label for Rocuronium Bromide Injection, 10 mg/mL strength, in a 5 mL multiple dose vial. The label includes a red warning about its paralytic effect and the necessity for facilities to have artificial respiration available. It lists active ingredients, storage instructions, and the labeler Fresenius Kabi USA, LLC. The product NDC is 63323-426.*
FDA Label Image

Roc04 0004 07

Roc04 0004 07
Rocuronium Bromide Injection 10 mg/mL, 50 mg per 5 mL (10 x 5 mL multiple dose vials), by Fresenius Kabi USA, LLC. The label highlights it as a paralyzing agent for intravenous use with warnings on respiratory arrest and storage instructions. Contains 10 mg rocuronium bromide per mL with 2 mg sodium acetate, adjusted to pH 4.*
FDA Label Image

Roc04 0004 08

Roc04 0004 08
Rocuronium Bromide Injection 10 mg/mL in a 10 mL multiple dose vial label from Fresenius Kabi USA, LLC. The label states the drug is sterile, nonpyrogenic, and warns it is a paralyzing agent causing respiratory arrest, for intravenous use only, Rx only. It includes storage instructions and dosage warnings, with the NDC 63323-426-01 visible, alongside barcode and lot/expiration placeholders.*
FDA Label Image

Roc04 0004 09

Roc04 0004 09
Rocuronium Bromide Injection 10 mg/mL (100 mg per 10 mL) in multiple-dose vials. The sterile, nonpyrogenic solution is labeled as a paralyzing agent for intravenous use, with a warning about respiratory arrest and the need for artificial respiration. It is supplied by Fresenius Kabi USA, LLC with storage and usage instructions included.*
FDA Label Image

Roc04 0004 10

Roc04 0004 10
Label for Rocuronium Bromide Injection, a 10 mg/mL solution for intravenous use. The label indicates it is a paralyzing agent with instructions to peel off and apply to a syringe. It includes spaces to record date, time, and administering person. The product is prescription only.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.